VAM Email Alert: March 2021

March 2021

** Advocacy Opportunity: Department of Defense Seeks the Help of Myeloma Patients

Volunteers Sought to Advance Myeloma Research: The IMF Advocacy Team heavily lobbied Congress. Now, myeloma researchers can apply for research funds through the Department of Defense’s Congressionally Directed Medical Research Program (CDMRP). With this inclusion, the IMF now has a unique opportunity to nominate myeloma patients or caregivers to apply for the role of consumer reviewer for the program. Consumer reviewers in this program act as the voice of all myeloma patients and help select what research proposals end up with funding. Individuals who have been nominated in the past do NOT need to be nominated again. They will remain in the pool of eligible consumer reviewers. Please email Danielle Doheny at [email protected] (mailto:[email protected]) to learn more about this opportunity.


Senate Holds Hearing Discussing Toxic Exposures

On March 10, 2021, the Senate Veterans’ Affairs Committee held a hearing entitled “Military Toxic Exposures: The Human Consequences of War.” The hearing focused on what steps could be taken to ensure veterans who develop illnesses as a result of toxic exposures receive proper care and benefits.

Chairman Jon Tester (D-MT) strongly believes action must be taken to help those who faced toxic exposures stating “We must develop a comprehensive process that is able to quickly deliver care and benefits to veterans as science develops around currently known and newly discovered exposures, without Congressional action,” said Chairman Tester. “This system must prioritize serving veterans’ urgent needs and delivering lifesaving care. Only then will we begin to fulfill the promises we made to care for those who sacrificed so much on our behalf.”

We are closely monitoring the issues surrounding toxic exposures as myeloma has been linked to them. The hearing can be viewed here ( .


Bipartisan Toxic Exposures Legislation Introduced

A bipartisan group of legislators introduced legislation aimed at helping individuals who have developed conditions as a result military connected toxic exposures. S.927 and H.R.2127 Toxic Exposure in the American Military (TEAM) Act. According to the Senate bill leads, the bill is “bipartisan legislation that fundamentally reforms and improves how veterans exposed to toxic substances receive health care and benefits from the Department of Veterans Affairs (VA).”

To view more about the TEAM Act and how it could help veterans who develop illnesses like myeloma as a result of toxic exposures, click here ( .
This post was written by
Comments are closed.